Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05153551 · ClinicalTrials.gov registry record · NA
Pediatric Early Autism Recognition System: PEARS
A NA study of Autism Spectrum Disorder, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT05153551: Completed NA study of Autism Spectrum Disorder, sponsored by University of Michigan.
NCT05153551 is a NA study of Autism Spectrum Disorder that has completed, run by University of Michigan. The registered enrollment target is 60 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05153551, a NA study of Autism Spectrum Disorder, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of the study is to assess a new autism evaluation model that would include the addition of a Level-2 autism screener, the Rapid Interactive Screening Test for Autism in Toddlers (RITA-T), to the developmental screening already done by the child's pediatrician. The study hypotheses: 1. The PEARS intervention will show high feasibility to primary care physicians (PCPs) and patient families. 2. The PEARS intervention will lead to increased parent activation around autism diagnosis.
Primary Outcome
This is based on a 6 question feasibility survey (score of 24 or greater would be considered feasible).
Conditions Studied
Interventions
- OTHER Play-based assessment (RITA-T)
Study Locations (3)
Michigan
- Michigan Medicine Briarwood Center for Women, Children, and Young Adults. - Ann Arbor
- Michigan Medicine Brighton Health Center - Brighton
- Michigan Medicine Northville Health Center - Northville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2022-10-18 |
| Phase | NA |
What the finished NCT05153551 record still lists
NCT05153551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Play-based assessment (RITA-T) is the first listed.
NCT05153551 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05153551 about?
NCT05153551 is a clinical study titled "Pediatric Early Autism Recognition System: PEARS". The goal of the study is to assess a new autism evaluation model that would include the addition of a Level-2 autism screener, the Rapid Interactive Screening Test for Autism in Toddlers (RITA-T), to the developmental screening already done by the child's pediatrician. The study hypotheses: 1. The...
What is the current status of trial NCT05153551?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-01-27. Estimated completion is 2022-10-18.
What conditions does trial NCT05153551 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT05153551?
The interventions under investigation include: Play-based assessment (RITA-T) (OTHER).
Who is sponsoring clinical trial NCT05153551?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05153551 being conducted?
This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05153551's enrollment target sits among peer trials
60 118th of 224 higher than 95 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI